Personalized medicine for cancer patients in a new technology era

April 15, 2010 | Source: Physorg.com

Published online Wednesday in Nature, a paper authored by over 200 members of the International Cancer Genome Consortium (ICGC) describes a new era of personalized medicine for cancer patients.

“Given the tremendous potential for relatively low-cost genomic sequencing to reveal clinically useful information, we anticipate that in the not so distant future, partial or full cancer genomes will routinely be sequenced as part of the clinical evaluation of cancer patients,” say the authors in the paper.